Browsing Category
S-4 Filing
961 posts
Focus Impact Files Proxy on DevvStream Deal
The deal was announced in September at an implied enterprise value of $212.8 million. Terms call for the issuance of $50,287,043 shares and 25,123,481 warrants to DevvStream investors.
May 3, 2024
Evergreen Postpones Vote in Pursuit of Another Extension
Evergreen is broadly focused on the technology sector in the ASEAN region, though it has yet to announce a deal.
May 3, 2024
PowerUp Acquisition Calls Meeting to Vote on 9-Month Extension Plan
Redemptions of nearly 94% left PowerUp with about $19 million in trust ahead of an extension vote a year ago. The SPAC had raised $287.5 million in a February 2022 IPO.
May 2, 2024
Feutune Light Files Prospectus to Issue 60M Shares for Thunder Power Deal
The deal also includes up to 20 million earnout shares that would vest in two tranches if the EV maker reaches certain financial thresholds over the next two years.
May 2, 2024
Catcha Seeks 3 More Months to Complete Oft-Delayed Crown LNG Merger
Catcha and Crown announced the deal back in August at a pre-money valuation of approximately $600 million, and a pro forma enterprise value of the combined company at $685 million. The SPAC's shareholder vote on the merger has been postponed three times.
May 2, 2024
Inception Growth Acquisition Amends Proxy on $140M AgileAlgo Deal
The target is a British Virgin Islands company that, through its Singapore-based subsidiary, AgileAlgo Pte Ltd., is a maker of enterprise-grade natural language code generator for machine-learning and data management platforms.
May 1, 2024
TOYO Solar Files Amended F-4, Clearing Final Hurdle for Blue World Acquisition Vote
TOYO focuses on solar photovoltaic products in Southeast Asia.
May 1, 2024
Broad Capital Files Proxy on $90M Open Markets Deal
The target provides trading and wealth management tech solutions.
May 1, 2024
Achari Ventures I Files Prospectus on $176M Vaso Deal
The target is a diversified medical technology company with several specialties: managed IT systems and services, including healthcare software solutions and network connectivity services; professional sales services for diagnostic imaging products; and design, manufacture and sale of proprietary medical devices.
May 1, 2024
Atlantic Coastal II Files Proxy on $500M Abpro Deal
The target is a biotechnology company focused on next-generation antibody therapies for severe and life-threatening diseases.
May 1, 2024